A
Aspeya
Venture Capital
Philip Morris International's wholly-owned investment subsidiary focused on consumer health, cannabinoids, and oral and intra-oral delivery therapeutics.
Lausanne, Switzerland · 2+ investments
Growth
Biotech
Digital Health
- Headquarters
- Lausanne, Switzerland
- Founded
- 2006
- Total Investments
- 2
- Last Investment
- May 2026
- Geographic Focus
- Europe
Investment Thesis
Corporate investment arm of Philip Morris International, deploying capital into consumer health, inhaled therapeutics, and oral drug-delivery innovations adjacent to PMI's harm-reduction strategy.
Aspeya is a Venture Capital firm based in Lausanne, Switzerland. It has made 2 investments in Biotech and Digital Health.
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.